Search
Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.
Company or person4
RANGE IMPACT, INC.
Company
IMPACT BIOMEDICAL INC.
Company
Ingersoll Rand Inc.
Company
IMPINJ INC
Company
Primary record20
Acumen Pharmaceuticals, Inc. filed 8-K
Item 1.02 Termination of a Material Definitive Agreement. As previously disclosed in its Current Report on Form 8-K filed on November 10, 2023, Acumen Pharmaceuticals, Inc. (the “Company”) entered into a Loan and Securit
SOUNDHOUND AI, INC. filed 8-K
Item 2.02 Results of Operations and Financial Condition. On November 5, 2026 , SoundHound AI, Inc. (the “Company”) issued a press release announcing financial results and operational highlights for the third quarter ende
Ingersoll Rand Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Retirement of Michael Weatherred, Senior Vice President, Precis
REPUBLIC SERVICES, INC. filed 8-K
Item 2.02 Results of Operations and Financial Condition . 3 Item 7.01 Regulation FD Disclosure. 3 Item 8.01 Other Events. 4 Item 9.01 Financial Statements and Exhibits . 4 SIGNATURES 5 EX-99.1 EX-104 2 Item 2.02 Results
Guidewire Software, Inc. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. Acquisition Agreement On October 27, 2026, Guidewire Software, Inc. (the “Company”) entered into an agreement for the sale and purchase of Hyperexponential Ltd (“hype
Blackstone Real Estate Income Trust, Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition Certain Preliminary Estimated Unaudited Financial Results for the Nine Months ended September 30, 2026 On October 22, 2026 , Blackstone Real Estate Income Trust, In
Azitra, Inc. filed 8-K
Item 3.03 Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current Report on Form 8-K (the “Current Report”) is incorpor
EBAY INC filed 8-K
Item 2.02 Results of Operations and Financial Condition. On October 20, 2026, eBay Inc. (the “Company” or “eBay”) announced a restructuring plan (the “Plan”) intended to align its teams and resources with its top strateg
Medline Inc. filed 8-K
Item 7.01. Regulation FD Disclosure. On October 14, 2026, Medline Inc. (the “ Company ”) initiated a voluntary field action involving the removal, discontinuation, and market exit of all Medline Brand beds , including ho
Moleculin Biotech, Inc. filed 8-K
Item 3.03. Material Modifications of Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 herein is incorporated by reference into this Item 3.03. Item 5.03
Invesco Commercial Real Estate Finance Trust, Inc. filed 8-K
Item 8.01 Other Events. Invesco Commercial Real Estate Finance Trust, Inc. (referred to herein as the "Company," "we," "our," or "us") is filing this Current Report on Form 8-K in order to provide an update regarding our
Fortune Brands Innovations, Inc. filed 8-K
Item 2.06. Material Impairments. As previously disclosed, as of June 27, 2026, Fortune Brands Innovations, Inc. (the Company ) performed a recoverability test of the Company s Fiberon asset group within the Outdoors segm
Super Micro Computer, Inc. filed 8-K
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers Chief Financial Officer Transition On October 14, 2026, the Boar
Entrada Therapeutics, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 14, 2026, the Company issued a press release titled Entrada Therapeutics Announces Positive Results from the First Cohort of Participants with Duchenne Muscular Dystrophy (D
IMPACT BIOMEDICAL INC. filed 8-K
Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year On November 24, 2025, the Board of Directors ( the Board ), subject to the requisite approval of the shareholders of Impact BioMedical Inc
PLAYSTUDIOS, Inc. filed 8-K
Item 2.06 Material Impairments. On September 30, 2026, PLAYSTUDIOS, Inc. (the Company ) made the decision to cease operation of the Company s product called Tetris Block Party. The Company has determined that this decisi
RANGE IMPACT, INC. filed 8-K
Item 1.01 Entry into a Material Definitive Agreement. MRR Option Transition Agreement and MRR Subscription Agreement On September 30, 2026, Range Bluegrass Land, LLC ( Range Bluegrass ), a wholly owned indirect subsidiar
AbbVie Inc. filed 8-K
Item 2.02 Results of Operations and Financial Condition Reported GAAP earnings and adjusted non-GAAP earnings for the third quarter of 2026 are expected to include acquired IPR&D and milestones expense of $216 million on
F&G Annuities & Life, Inc. filed 8-K
Item 2.02. Results of Operations and Financial Condition The information contained in Item 7.01 of this Current Report on Form 8-K under the heading Preliminary estimates for investment income from alternative investment
Camping World Holdings, Inc. filed 8-K
Item 7.01 Regulation FD Disclosure. On October 5, 2026, Camping World Holdings, Inc. (the Company ) announced that, reflecting the operating trends and other factors described below, the Company now expects full-year 202